These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


106 related items for PubMed ID: 2494007

  • 1. Recombinant tissue-type plasminogen activator in canine embolic pulmonary hypertension. Effects of bolus versus short-term administration on dynamics of thrombolysis and on pulmonary vascular pressure-flow characteristics.
    Prewitt RM, Shiffman F, Greenberg D, Cook R, Ducas J.
    Circulation; 1989 Apr; 79(4):929-38. PubMed ID: 2494007
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Thrombolytic therapy in canine pulmonary embolism. Comparative effects of urokinase and recombinant tissue plasminogen activator.
    Prewitt RM, Hoy C, Kong A, Gu SA, Greenberg D, Cook R, Chan SM, Ducas J.
    Am Rev Respir Dis; 1990 Feb; 141(2):290-5. PubMed ID: 2105682
    [Abstract] [Full Text] [Related]

  • 4. Rapid reversal of canine thromboembolic pulmonary hypertension by bolus injection of the novel recombinant plasminogen activator BM 06.022.
    Martin U, Sponer G, Strein K.
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):455-61. PubMed ID: 7681508
    [Abstract] [Full Text] [Related]

  • 5. Effects of hydralazine and increased cardiac output on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolism.
    Prewitt RM, Downes AM, Gu SA, Chan SM, Ducas J.
    Chest; 1991 Mar; 99(3):708-14. PubMed ID: 1899825
    [Abstract] [Full Text] [Related]

  • 6. Effect of low-molecular-weight heparin on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolism.
    Werier J, Ducas J, Gu S, Chan SM, Prewitt RM.
    Chest; 1991 Aug; 100(2):464-9. PubMed ID: 1650681
    [Abstract] [Full Text] [Related]

  • 7. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism.
    Levine M, Hirsh J, Weitz J, Cruickshank M, Neemeh J, Turpie AG, Gent M.
    Chest; 1990 Dec; 98(6):1473-9. PubMed ID: 2123152
    [Abstract] [Full Text] [Related]

  • 8. Optimizing coronary thrombolysis with i.v. administration of recombinant tissue plasminogen activator. Single bolus vs double bolus vs front-loading.
    Prewitt RM, Schick U, Ducas J.
    Chest; 1996 Feb; 109(2):510-5. PubMed ID: 8620730
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of recombinant tissue-type plasminogen activator on life-threatening acute pulmonary thromboembolism in a canine model: a comparative study of e6010 and alteplase.
    Tagami H, Utoh J, Sun LB, Okamoto K, Moriyama S, Kunitomo R, Kitamura N.
    Ann Thorac Cardiovasc Surg; 2000 Oct; 6(5):299-303. PubMed ID: 11173335
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group.
    Goldhaber SZ, Agnelli G, Levine MN.
    Chest; 1994 Sep; 106(3):718-24. PubMed ID: 8082347
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A new short infusion dosage regimen of recombinant tissue plasminogen activator in patients with venous thromboembolic disease.
    Levine MN, Weitz J, Turpie AG, Andrew M, Cruickshank M, Hirsh J.
    Chest; 1990 Apr; 97(4 Suppl):168S-171S. PubMed ID: 2108854
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.